VI Partners

VI Partners stands as Switzerland's most established venture capital firm, with a distinguished history dating back to 2001. For over two decades, this investment powerhouse has dedicated its resources to fueling innovation across the Technology and Healthcare sectors, deploying more than CHF 330 million across a diverse portfolio of 70 promising startups. Their longevity in the Swiss venture ecosystem demonstrates a consistent ability to identify high-potential companies and guide them through various growth stages.

The firm's investment strategy centers on identifying disruptive technologies and breakthrough healthcare solutions with significant market potential. VI Partners typically engages with companies from early-stage funding rounds through to growth capital, providing not just financial support but also strategic guidance and industry connections. Their healthcare investments span biotechnology, medical devices, digital health platforms, and pharmaceutical innovations, while their technology portfolio encompasses enterprise software, fintech, cleantech, and advanced manufacturing solutions.

What distinguishes VI Partners is their exceptional network of blue-chip backers, including some of Switzerland's most prestigious corporations and institutions. Their managed funds receive support from ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva, and ZKB. This impressive roster is complemented by the European Investment Fund and numerous other institutional investors, creating a powerful ecosystem that portfolio companies can leverage for partnerships, market access, and follow-on funding.

Throughout its history, VI Partners has established a reputation for patient capital combined with active involvement in their portfolio companies' development. Their investment professionals bring deep sector expertise and operational experience, allowing them to provide meaningful guidance on strategic decisions, talent acquisition, and international expansion. The firm's track record includes several successful exits through acquisitions by global industry leaders and public market listings, cementing their position as a cornerstone of Switzerland's innovation economy and a gateway for international investors seeking exposure to the region's technological and healthcare advancements.